Beth Israel Deaconess Medical Center Professor of Surgery, Beth Israel Deaconess Medical Center
Urology
Dr. William C. Dewolf, MD
|
|
Give Review
Doctor William C. Dewolf, MD practices Urology. He studied medicine at Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19 in research and 29 in primary care medicine He over the years received 3 awards: "Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACS)". William C. Dewolf is a published doctor. He has 40 papers published. The most current publication "Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance." William C. Dewolf is registered with Medicare.
Publications
- Low free testosterone levels predict disease reclassification in men with prostate Cancer undergoing active surveillance.
- Diagnosis of relevant prostate Cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies.
- Comparing Costs of Robotic, Laparoscopic, and Open Partial Nephrectomy.
- Expanded prostate Cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the rout...
- Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate Cancer during active surv...
- Re: Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic Renal cell carcinoma. Editorial comment.
- The human Cancer and stem cell marker podocalyxin interacts with the glucose-3-transporter in malignant pluripotent stem cells.
- The hybrid of basic science and clinical training for the urologic oncologist: Necessity or waste?
- MR imaging of Renal masses: correlation with findings at surgery and pathologic analysis.
- Lower limits of detection using magnetic resonance imaging for solid components in cystic Renal neoplasms.
- c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate Cancer cells.
- The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma.
- The continued decline of formal urological education of medical students in the United States: does it matter?
- Low age adjusted free testosterone levels correlate with poorly differentiated prostate Cancer.
- A multi-institutional randomized controlled trial of adjuvant Web-based teaching to medical students.
- Quality of life following simultaneous placement of penile prosthesis with radical Prostatectomy.
- Use of thymosin beta15 as a urinary biomarker in human prostate Cancer.
- Magnetic resonance imaging findings in solitary fibrous tumor of the Kidney.
- Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate Cancer.
- Expression of transforming growth factor-beta 1 and growth in soft agar differentiate Prostate carcinoma-associated fibroblasts from normal Prostate fibroblasts.
- Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in pro...
- MR imaging of the Prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla.
- Development and initial evaluation of a novel urology curriculum for medical students.
- Development of validated instrument to measure medical student learning in clinical urology: a step toward evidence based education.
- Percent of cores positive for Cancer is a better preoperative predictor of Cancer recurrence after radical prostatectomy than prostate specific antigen.
- The cell cycle and its relevance to the urologist.
- Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate Cancer.
- Determinations of Prostate volume at 3-Tesla using an external phased array coil: comparison to pathologic specimens.
- Human embryonal carcinoma tumor Antigen, Gp200/GCTM-2, is podocalyxin.
- Extended Prostate needle biopsy improves concordance of Gleason grading between Prostate needle biopsy and radical Prostatectomy.
- The relationship of prostate gland volume to extended needle biopsy on prostate Cancer detection.
- Association between prostate Cancer and serum testosterone levels.
- Serum levels of insulin-like growth factor-1 and insulin-like growth factor-1 binding proteins after radical Prostatectomy.
- Decreasing Prostate specific antigen value leading to the diagnosis of a pituitary adenoma.
- Does the outpatient setting provide the best environment for medical student learning of urology?
- P53 and Fas are sequential mechanisms of Testicular germ cell apoptosis.
- Re: are doctors examining Prostates in university hospital?
- MR classification of Renal masses with pathologic correlation.
- Spaced education improves the retention of clinical knowledge by medical students: a randomised controlled trial.
Schools
Northwestern University The Feinberg School Of Medicine
PresbyterianSt Luke39schicago
University Of MinnesotaMinneapolis
Dana Farber Cancer Institute
Harvard Med School
Minneapolis Va Med Center
Procedures Preformed
- AdRenalectomy
- Cystometry
- Cystotomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACS)
Education
-
University of Minnesota at Fairview -
Rush University Medical Center -
Northwestern University Feinberg School of Medicine
Hospital
-
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1689612970 | |
| NPPES Provider LastName | DEWOLF | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 02215 | |
| NPPES Provider State | MA | |
| Specialty Description | Urology | |
| Total Claim Count | 1368.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1689612970 |
| Last Name Of The Provider | DEWOLF |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
|
Dr. Theodore J. Ongaro, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Bayan T. Takizawa |
|
|
Dr. Kevin R. Loughlin, MD |
|
|
Dr. Roshan M. Patel, MD |
|
|
Dr. Briony K. Varda, MD |
|
|
Dr. Joshua R. Kaplan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Courtney K. Rowe, MD |
|
|
Dr. Caleb P. Nelson, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Stephen P. Dretler, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Dianne E. Sacco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashley J. Brandon, MD
This Doctor is OpenDoctor Recommended.
|